| Mitochondrial dynamics and cell death in heart failure | 2016/02/12 | English | 101 |
| NADPH oxidases and cardiac remodelling | 2010/07/25 | English | 101 |
| Sympathetic–parasympathetic interaction in health and disease: abnormalities and relevance in heart failure | 2010/06/25 | English | 100 |
| Epidemiology of acute heart failure syndromes | 2007/04/21 | English | 99 |
| Myocardial ischemia and coronary disease in heart failure | 2019/07/22 | English | 98 |
| Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy | 2018/10/22 | English | 98 |
| The Cardiorenal Syndrome: Lessons from the ADHERE Database and Treatment Options | 2005/01/01 | English | 97 |
| Role of endothelial dysfunction in heart failure | 2019/11/04 | English | 96 |
| Aldosterone Biosynthesis, Regulation, and Classical Mechanism of Action | 2005/01/01 | English | 95 |
| A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure | 2012/06/26 | English | 94 |
| Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart | 2014/09/06 | English | 94 |
| Role of cell death in the progression of heart failure | 2016/02/12 | English | 93 |
| Systematic review of economic burden of heart failure | 2017/11/10 | English | 93 |
| Mitochondrial centrality in heart failure | 2008/01/05 | English | 93 |
| A novel approach to improve cardiac performance: cardiac myosin activators | 2009/02/21 | English | 92 |
| Tissue inhibitor of metalloproteinases (TIMPs) in heart failure | 2011/06/30 | English | 91 |
| Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity | 2014/01/08 | English | 91 |
| Relaxin, a pleiotropic vasodilator for the treatment of heart failure | 2008/12/20 | English | 89 |
| Metabolic dysfunction in diabetic cardiomyopathy | 2013/02/27 | English | 89 |
| Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials | 2019/04/28 | English | 89 |
| The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence | 2008/12/27 | English | 88 |
| Iron and anemia in human biology: a review of mechanisms | 2008/03/25 | English | 87 |
| T1 mapping in cardiac MRI | 2017/06/16 | English | 87 |
| Role of autophagy in heart failure associated with aging | 2010/04/10 | English | 87 |
| Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials | 2019/05/24 | English | 86 |
| Quality of life of chronic heart failure patients: a systematic review and meta-analysis | 2019/11/19 | English | 86 |
| Fibroblast growth factor-2 and cardioprotection | 2007/05/22 | English | 85 |
| Natural history and therapy of AL cardiac amyloidosis | 2014/12/02 | English | 84 |
| Biomarkers in heart failure: the past, current and future | 2019/06/10 | English | 84 |
| A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial | 2011/09/20 | English | 82 |